Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$191.17 - $325.63 $5.45 Million - $9.29 Million
28,525 Added 69.47%
69,587 $22.7 Million
Q4 2023

Feb 07, 2024

SELL
$160.99 - $215.69 $7.21 Million - $9.66 Million
-44,792 Reduced 52.17%
41,062 $7.82 Million
Q3 2023

Nov 09, 2023

BUY
$194.33 - $283.97 $1.38 Million - $2.02 Million
7,107 Added 9.03%
85,854 $17.1 Million
Q2 2023

Aug 09, 2023

SELL
$223.05 - $302.68 $1.75 Million - $2.37 Million
-7,824 Reduced 9.04%
78,747 $22.5 Million
Q1 2023

May 12, 2023

SELL
$175.41 - $217.92 $739,177 - $918,314
-4,214 Reduced 4.64%
86,571 $18.8 Million
Q4 2022

Feb 09, 2023

BUY
$204.38 - $296.82 $614,161 - $891,944
3,005 Added 3.42%
90,785 $18.7 Million
Q3 2022

Nov 10, 2022

BUY
$195.21 - $310.53 $2.18 Million - $3.47 Million
11,181 Added 14.6%
87,780 $24.4 Million
Q2 2022

Aug 12, 2022

SELL
$115.91 - $214.48 $1.31 Million - $2.43 Million
-11,325 Reduced 12.88%
76,599 $14.6 Million
Q1 2022

May 13, 2022

SELL
$127.96 - $207.36 $508,257 - $823,633
-3,972 Reduced 4.32%
87,924 $18.2 Million
Q4 2021

Feb 09, 2022

SELL
$165.13 - $241.83 $1.34 Million - $1.96 Million
-8,097 Reduced 8.1%
91,896 $16.4 Million
Q3 2021

Nov 12, 2021

SELL
$163.99 - $235.57 $924,575 - $1.33 Million
-5,638 Reduced 5.34%
99,993 $20.6 Million
Q2 2021

Aug 12, 2021

BUY
$131.45 - $201.49 $181,926 - $278,862
1,384 Added 1.33%
105,631 $20 Million
Q1 2021

May 14, 2021

SELL
$92.73 - $142.05 $1.29 Million - $1.98 Million
-13,945 Reduced 11.8%
104,247 $13.6 Million
Q4 2020

Feb 25, 2021

BUY
$67.44 - $103.72 $7.97 Million - $12.3 Million
118,192 New
118,192 $12.3 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.